Purchase Order W81K0019P0392

Award Date 9/13/19
Potential Completion Date 3/31/20
Potential Value $85K
Federal Agency
Medical Command
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order was awarded by the Medical Command (MEDCOM) component of the U.S. Army to Gen-Probe Incorporated, a large medical diagnostics company, for the provision of nucleic acid probe test kits. The $1,550,250.00 contract has an ultimate completion date of September 30, 2020. Gen-Probe Incorporated, the prime contractor, is a for-profit organization that specializes in molecular diagnostic testing systems, assays, and related products and services for the U.S. federal...
This is a firm fixed-price delivery order contract awarded by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company, for $574,651.50. The contract is for the delivery of APTIMA COMBO 2 KITS for the fiscal year 2021. This contract does not have a set-aside designation. Gen-Probe Incorporated is the prime contractor and has previously provided a variety of medical diagnostics products and services, including tests for infectious diseases, to federal...
This is a firm fixed price purchase order contract awarded by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company, for $240,122.50. The contract is for STD test kits, with no set-aside designation. Gen-Probe Incorporated has previously provided a variety of medical diagnostic equipment and supplies, including tests for infectious diseases, to federal agencies such as the Defense Health Agency, Department of Veterans Affairs, and Department of the...
This federal contract award is for a minimum guarantee delivery order with a firm fixed price of $456,519.00, issued by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company. The award does not have a set-aside designation. Through this contract, Gen-Probe Incorporated will provide a variety of goods and services, including APTIMA combo assay test kits for chlamydia and gonorrhea, APTIMA HIV-1 and hepatitis C virus tests, PANTHER FUSION systems and...
This is a firm fixed-price purchase order awarded by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company, for the provision of standard testing supplies. The contract has a potential value of $354,575.00 and a completion date of September 30, 2020. Gen-Probe Incorporated has a history of providing a variety of infectious disease testing products and services to federal agencies, including the Defense Health Agency, Department of Veterans Affairs,...
This contract award is for the APTIMA COMBO 2 ASSAY CT/GC diagnostic test kits produced by Gen-Probe Incorporated, a medical diagnostics company. The contract, placed by the Defense Health Agency, is a firm fixed-price purchase order for 50 units of the 250-test kits at $2,725 per unit, for a total potential value of $136,250. The contract has a completion date of September 30, 2022 and was awarded on September 16, 2022. This award does not have a set-aside designation. Gen-Probe Incorporated...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company that produces molecular diagnostic testing systems and assays. The contract is for the delivery of APTIMA SARS-CoV-2 tests to detect COVID-19, with a potential value of $745,185.00 and a completion date of March 31, 2023. The contract is part of the agency's efforts to procure necessary medical supplies related to the Coronavirus COVID-19 national interest...
This is a firm fixed-price delivery order contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Gen-Probe Incorporated, a medical diagnostics company, for the provision of APTIMA COMBO 2, 250-test kits and PANTHER systems. The potential value of the contract is $442,050.00, with a completion date of July 31, 2018. The contract did not have a set-aside designation. Gen-Probe Incorporated has previously held various federal contracts to supply medical testing equipment...
This is a delivery order contract awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the APTIMA COMBO 2 ASSAY (CT/GC). The firm-fixed-price contract has a ceiling value of $497,300.00 and a completion date of August 31, 2022. The contract is not set aside and was awarded on November 29, 2021. Gen-Probe, as a specialized supplier in molecular diagnostics, has held numerous contracts with defense and civilian agencies to provide infectious disease...
This is a firm fixed-price delivery order awarded by the Department of the Navy Bureau of Medicine and Surgery to Gen-Probe Incorporated, a medical diagnostics company, for the supply of 250-test APTIMA COMBO 2 kits and PANTHER systems. The order has a potential value of $148,550.00 and a completion date of December 15, 2017. The contract does not have a set-aside designation. Gen-Probe Incorporated has a history of providing a variety of medical diagnostics products and services, including...

This firm fixed-price purchase order for $85,248.00 was awarded by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company, on September 13, 2019. The contract is for APTIMA COMBO 2, 250 TST KT, CT/NG test kits, with a completion date of March 31, 2020. This contract was not set aside and is not associated with a larger contract vehicle. Gen-Probe is a key supplier of molecular diagnostic testing systems, assays, and related products and services to federal agencies, including the Defense Health Agency, Department of Veterans Affairs, and others, particularly during the COVID-19 pandemic. The company has held numerous prime contracts and subcontracts to provide a wide range of infectious disease testing capabilities to support military personnel, veterans, and their families.

Generated 4/2/25, 4:15 PM